TIME FOR VIOXX TO PAY! (supplement for 'vioxx killed my husband.'...
by Phylo

It's time for Merck to Pay It's time for Merck to pay for Murder!   13 y  
More people died from vioxx then on 911. Allowing Merck to put vioxx back into the market is as insane as giving more planes to terrorist to fly into buildings. It's time for reckoning day, "Merck" will be running free to kill more people and now we have a president who is protecting them. This is too insane to be allowed! This will be a running journal of factual news as it evolves. People are welcome to contact me at anytime. I still want thier stories for my new book.
 
FDA Scientist Questions Need for COX-2 Drugs By Susan Heavey and Lisa Richwine WASHINGTON (Reuters) Feb 17 - A veteran U.S. Food and Drug Administration scientist on Thursday said he saw no need for COX-2 inhibitors, citing increased vascular risks. The FDA, which has come under fire in recent months as being slow to respond to serious side effects of drugs, is asking an advisory panel if COX-2 inhibitors offer enough benefits to stay on the market, if they need stronger warnings, and if further research is needed. Graham said he saw a ”class effect” of heart risk from the COX-2 in ...   read more



 
Merck will get away with Murder if this blog doesn't contine. So my book will continue until Merck hears it! This will be a contious update of the world of Merck & all pharmaceutical companies.   13 y  
There has never been a time in my life on this planet that I personally have witnessed the growth of pure evil presenting itself as a form of helping people! More people died from taking the drug vioxx, then on 911! It's time America declared war on all it's enemies. Merck is being protected with the bill Bush signed. Just like Osama Bin Laden is running free...so will Merck until people put a stop to it. By Susan Heavey and Lisa Richwine WASHINGTON (Reuters) Feb 17 - A veteran U.S. Food and Drug Administration scientist on Thursday said he saw no need for COX-2 inhibitors, citing increased vascular risks. The presentation by David Graham, associate director for science and medicine at the FDA's Office of Drug Safety, came on the second day of an unusual three-day meeting called by the FDA after Merck & Co. pulled Vioxx (rofecoxib) from the market in late September. The recall was prompted by a study showing the drug doubled the risk of MI and stroke. The FDA, which has come un
 
FDA Scientist Questions Need for COX-2 Drugs By Susan Heavey and Lisa Richwine WASHINGTON (Reuters) Feb 17 - A veteran U.S. Food and Drug Administration scientist on Thursday said he saw no need for COX-2 inhibitors, citing increased vascular risks. The presentation by David Graham, associate director for science and medicine at the FDA’s Office of Drug Safety, came on the second day of an unusual three-day meeting called by the FDA after Merck & Co. pulled Vioxx (rofecoxib) from the market in late September. The recall was prompted by a study showing the drug doubled the risk of MI ...   read more



 
 

Add Blog To Your Favorites!

With evey fiber of my being, I must keep this blog alive. It may save lives. more...

Last Activity: 13 y ago
2 Messages   Last message 13 y ago
1 Comments   Last comment 13 y ago

viewed 15,442 times
Created: 13 y   Feb 24 2005

Comments (1 of 1):
I can't agree with… #5309… 13 y
All Comments (1)

Blogs by Phylo (1):
Vioxx Killed My Husband  13 y  (1)

Similar Blogs (10 of 185):
Jimmy Bigger Pennis  by masspennis87  61 min
Benefits of Hiring …  by stevenchristian  128 min
Goldie Shrink Fibro…  by fibroidstreat7  133 min
Reynaldo Back Pain  by backpainclear15  11 h
Plant Your Dream!  by YourEnchantedGardener  35 h
Flat Belly Detox Re…  by detoxproducts37  37 h
Your Skin and Gluta…  by fungusnuker  51 h
Synergy Treatment P…  by NEO.world  56 h
EarthSpirit  by Mayah  78 h
Better Health Chiro…  by dr.brent.wells  5 d
All Blogs (1,019)


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2018  www.curezone.org

6.891 sec, (1)